RPS6KB1 and breast cancer: The salient point of our experiments is that we chose to compare the expression levels of p-S6K1 in breast cancer stem cells with a radio-resistant phenotype (CD44high/CD24low MCF7 cells) to that of MCF7 breast cancer cells.